Cemented as an essential technology in clinical laboratories, coagulation analyzers continue to receive strong satisfaction ratings as their capabilities expand. The benefits of automated clot detection, assessment of clotting factors, and the application of chromogenic, immunologic, and other methodologies render this modern technology essential.

This year sees an appreciable uptick in projected analyzer adoptions with over half of labs (53%) planning to acquire new coagulation analyzers, up from 39% last year.

Laboratories are largely pleased with their coagulation analyzers, as 83% award their systems the highest ratings.

Click here to view a larger version of this Chart.

Werfen maintains a slim lead among systems in use, with Stago and Sysmex also well represented.

Click here to view a larger version of this Chart.

Stago, Werfen, and Sysmex lead amongst vendors under consideration, with Siemens Healthineers and Beckman Coulter also garnering notice.

Of those facilities planning to adopt a new coagulation analyzer system, nearly three-quarters (72%) anticipate doing so beyond the next two years.